Today, The Blueprint Medicines Corp.’s (BPMC) “Outperform” Rating Reiterate at Wedbush

Today, The      Blueprint Medicines Corp.’s (BPMC) “Outperform” Rating Reiterate at Wedbush

Wedbush reaffirmed their outperform rating on shares of Blueprint Medicines Corp. (NASDAQ:BPMC) in a research note issued to investors on Tuesday. The firm currently has a $41.00 target price on the stock, down from their previous target price of $43.00. Several other research firms have also issued reports on BPMC. Zacks Investment Research lowered shares of Blueprint Medicines Corp. from a buy rating to a hold rating in a research report on Tuesday, November 15th. Canaccord Genuity set a $35.00 price target on shares of Blueprint Medicines Corp. and gave…

Today, The 617 Shares of Cintas Corp. (CTAS) are sold by Exxonmobil Investment Management Inc. TX

Today, The      617 Shares of Cintas Corp. (CTAS) are sold by Exxonmobil Investment Management Inc. TX

Exxonmobil Investment Management Inc. TX reduced its position in shares of Cintas Corp. (NASDAQ:CTAS) by 2.8% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 21,818 shares of the company’s stock after selling 617 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Cintas Corp. were worth $2,457,000 as of its most recent SEC filing. Several other large investors have also modified their holdings of CTAS. Quadrant Capital Group LLC boosted its stake in shares of Cintas Corp. by 0.8% in…

Today, The Biogen Inc. (BIIB) Upgraded to Buy at Vetr Inc.

Today, The      Biogen Inc. (BIIB) Upgraded to Buy at Vetr Inc.

Vetr upgraded shares of Biogen Inc. (NASDAQ:BIIB) from a hold rating to a buy rating in a report published on Monday morning. Vetr currently has $316.41 target price on the biotechnology company’s stock. A number of other analysts have also recently commented on the company. JPMorgan Chase & Co. reiterated a buy rating and set a $386.00 price objective on shares of Biogen in a research report on Friday, September 16th. BMO Capital Markets reiterated a market perform rating and set a $304.00 price objective on shares of Biogen in…

Today, The Oregon Public Employees Retirement Fund Reduces stake in Trimble Navigation Ltd. (TRMB)

Today, The      Oregon Public Employees Retirement Fund Reduces stake in Trimble Navigation Ltd. (TRMB)

Oregon Public Employees Retirement Fund cut its position in Trimble Navigation Ltd. (NASDAQ:TRMB) by 1.0% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 86,843 shares of the company’s stock after selling 870 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Trimble Navigation were worth $2,480,000 as of its most recent SEC filing. Other large investors have also made changes to their positions in the company. Arizona State Retirement System increased its position in shares of Trimble Navigation by…

Today, The Bank of Nova Scotia (BNS) Expected to Earn Q1 2017 Earnings of $1.52 Per Share

Today, The      Bank of Nova Scotia (BNS) Expected to Earn Q1 2017 Earnings of $1.52 Per Share

Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) – Research analysts at Desjardins issued their Q1 2017 earnings estimates for shares of Bank of Nova Scotia in a research report issued to clients and investors on Tuesday. Desjardins analyst D. Young expects that the firm will earn $1.52 per share for the quarter. Desjardins also issued estimates for Bank of Nova Scotia’s Q2 2017 earnings at $1.57 EPS, Q3 2017 earnings at $1.60 EPS, Q4 2017 earnings at $1.61 EPS, FY2017 earnings at $6.30 EPS and FY2018 earnings at $6.80 EPS. BNS…

Today, The Glencore PLC (GLEN) Given a GBX 300 Price Target by Independent Research GmbH Analysts

Today, The      Glencore PLC (GLEN) Given a GBX 300 Price Target by Independent Research GmbH Analysts

Glencore PLC (LON:GLEN) has been given a GBX 300 ($3.72) target price by equities researchers at Independent Research GmbH in a report released on Friday. The firm currently has a “neutral” rating on the natural resources company’s stock. Independent Research GmbH’s price target indicates a potential upside of 5.80% from the stock’s previous close. Other research analysts have also recently issued research reports about the company. Canaccord Genuity restated a “hold” rating and issued a GBX 250 ($3.10) price target on shares of Glencore PLC in a research report on…

Today, The Mizuho Downgraded Gap Inc. (GPS) Price Target to $27.00

Today, The      Mizuho Downgraded Gap Inc. (GPS) Price Target to $27.00

Gap Inc. (NYSE:GPS) had its price target decreased by stock analysts at Mizuho from $28.00 to $27.00 in a report released on Friday, StockTargetPrices.com reports. The firm presently has a “neutral” rating on the apparel retailer’s stock. Mizuho’s price objective would suggest a potential upside of 7.78% from the company’s previous close. Other equities analysts have also recently issued reports about the stock. Jefferies Group set a $32.00 target price on shares of Gap and gave the company a “buy” rating in a research note on Saturday, October 8th. Cowen…

Today, The Oppenheimer & Co. Inc. decides to keep it stake in HCA Holdings Inc. (HCA) to the level of $2,460,000

Today, The      Oppenheimer & Co. Inc. decides to keep it stake in HCA Holdings Inc. (HCA) to the level of $2,460,000

Oppenheimer & Co. Inc. lowered its position in shares of HCA Holdings Inc. (NYSE:HCA) by 13.9% during the third quarter, Holdings Channel reports. The fund owned 32,527 shares of the company’s stock after selling 5,233 shares during the period. Oppenheimer & Co. Inc.’s holdings in HCA Holdings were worth $2,460,000 at the end of the most recent quarter. Several other large investors have also recently bought and sold shares of HCA. Acrospire Investment Management LLC boosted its stake in shares of HCA Holdings by 35.7% in the second quarter. Acrospire…

Today, The Oregon Public Employees Retirement Fund Sold shares of RPM International Inc. (RPM)

Today, The      Oregon Public Employees Retirement Fund Sold shares of RPM International Inc. (RPM)

Oregon Public Employees Retirement Fund cut its stake in shares of RPM International Inc. (NYSE:RPM) by 11.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 45,996 shares of the company’s stock after selling 5,965 shares during the period. Oregon Public Employees Retirement Fund’s holdings in RPM International were worth $2,471,000 as of its most recent SEC filing. A number of other hedge funds have also recently modified their holdings of RPM. Arizona State Retirement System raised its position in shares of…

Today, The BioTelemetry Inc. (BEAT) Research Coverage Started at Dougherty & Co

Today, The      BioTelemetry Inc. (BEAT) Research Coverage Started at Dougherty & Co

Analysts at Dougherty & Co started coverage on shares of BioTelemetry Inc. (NASDAQ:BEAT) in a note issued to investors on Friday, StockTargetPrices.com reports. The firm set a “buy” rating and a $26.00 price target on the stock. Dougherty & Co’s target price suggests a potential upside of 31.31% from the company’s current price. BEAT has been the subject of several other research reports. Sidoti began coverage on BioTelemetry in a report on Tuesday, September 13th. They issued a “buy” rating and a $27.00 price objective for the company. Lake Street…